SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-150867
Filing Date
2021-05-05
Accepted
2021-05-05 08:06:01
Documents
14
Period of Report
2021-05-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d400785d8k.htm   iXBRL 8-K 25243
2 EX-99.1 d400785dex991.htm EX-99.1 7146
6 GRAPHIC g400785dsp01.jpg GRAPHIC 3913
  Complete submission text file 0001193125-21-150867.txt   164171

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20210505.xsd EX-101.SCH 3102
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20210505_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20210505_pre.xml EX-101.PRE 11429
7 EXTRACTED XBRL INSTANCE DOCUMENT d400785d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 21891249
SIC: 2834 Pharmaceutical Preparations